Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$89.44
-2.9%
$89.23
$81.97
$137.49
$155.84B0.6112.09 million shs1.80 million shs
Dover Corporation stock logo
DOV
Dover
$213.47
-0.4%
$216.96
$158.97
$237.54
$28.84B1.161.13 million shs90,805 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-2.09%-3.79%+4.70%-8.95%-30.26%
Dover Corporation stock logo
DOV
Dover
-0.60%-0.16%-1.22%-1.86%+13.45%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$89.44
-2.9%
$89.23
$81.97
$137.49
$155.84B0.6112.09 million shs1.80 million shs
Dover Corporation stock logo
DOV
Dover
$213.47
-0.4%
$216.96
$158.97
$237.54
$28.84B1.161.13 million shs90,805 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-2.09%-3.79%+4.70%-8.95%-30.26%
Dover Corporation stock logo
DOV
Dover
-0.60%-0.16%-1.22%-1.86%+13.45%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.93
Moderate Buy$118.4232.40% Upside
Dover Corporation stock logo
DOV
Dover
2.53
Moderate Buy$241.4313.10% Upside

Current Analyst Ratings Breakdown

Latest DOV and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/9/2026
Dover Corporation stock logo
DOV
Dover
Reiterated RatingOutperform$262.00
7/7/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
UpgradeSell (D+)Hold (C-)
7/6/2026
Dover Corporation stock logo
DOV
Dover
DowngradeBuy (B-)Hold (C+)
7/1/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Initiated CoverageOutperform$121.00
6/30/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
UpgradeStrong-Buy
6/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingOverweight$115.00
6/17/2026
Dover Corporation stock logo
DOV
Dover
UpgradeHold (C+)Buy (B-)
6/16/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C-)Sell (D+)
6/12/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price Target$120.00 ➝ $102.00
6/4/2026
Dover Corporation stock logo
DOV
Dover
Boost Price TargetEqual Weight$210.00 ➝ $230.00
5/27/2026
Dover Corporation stock logo
DOV
Dover
DowngradeBuy (B-)Hold (C+)
(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.51$6.65 per share13.44$30.35 per share2.95
Dover Corporation stock logo
DOV
Dover
$8.09B3.55$12.32 per share17.33$53.99 per share3.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5725.0614.781.6213.90%17.62%10.01%7/16/2026 (Estimated)
Dover Corporation stock logo
DOV
Dover
$1.09B$8.0226.7118.761.6413.30%18.01%10.10%7/23/2026 (Estimated)

Latest DOV and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2026Q2 2026
Dover Corporation stock logo
DOV
Dover
$2.72N/AN/AN/A$2.21 billionN/A
7/16/2026Q2 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.28N/AN/AN/A$12.52 billionN/A
4/23/2026Q1 2026
Dover Corporation stock logo
DOV
Dover
$2.27$2.28+$0.01$1.75$2.19 billion$2.05 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.82%+10.39%70.59%54 Years
Dover Corporation stock logo
DOV
Dover
$2.080.97%+1.00%25.94%70 Years

Latest DOV and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/12/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.87%7/15/20267/15/20268/17/2026
5/8/2026
Dover Corporation stock logo
DOV
Dover
quarterly$0.520.98%5/29/20265/29/20266/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Dover Corporation stock logo
DOV
Dover
0.35
1.87
1.32

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Dover Corporation stock logo
DOV
Dover
84.46%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Dover Corporation stock logo
DOV
Dover
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Dover Corporation stock logo
DOV
Dover
24,000134.66 million133.18 millionOptionable

Recent News About These Companies

Morgan Stanley Sees More Upside in Dover (DOV) Shares
Dover Announces 2026 Scholarship Program Winners

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$89.44 -2.67 (-2.90%)
As of 10:47 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Dover stock logo

Dover NYSE:DOV

$213.47 -0.80 (-0.37%)
As of 10:47 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide. The company's Engineered Products segment provides various equipment, component, software, solution, and services that are used in vehicle aftermarket, waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-market. This segment offers manual and power clamp, rotary and linear mechanical indexer, conveyor, pick and place unit, glove port, and manipulator, as well as end-of-arm robotic gripper, slide, and end effector; winches, hoists, bearings, drives, and electric monitoring system; and radio frequency and microwave filters and switches, and signal intelligence solutions. Its Clean Energy & Fueling segment offers component, equipment, and software and service solution enabling safe storage and transport of fuel, cryogenic gases, and hazardous fluids, as well as operation of retail fueling and vehicle wash establishment. The company's Imaging & Identification segment provides precision marking and coding, product traceability equipment, brand protection, and digital textile printing equipment and solution, as well as related consumable, software, and service to packaged and consumer goods, pharmaceutical, manufacturing, fashion and apparel, and other end-market. Its Pumps & Process Solutions segment manufactures specialty pump, connector, flow meter, fluid connecting solution, plastics and polymer processing equipment, and engineered components for rotating and reciprocating machines. The company's Climate & Sustainability Technologies segment manufactures refrigeration system, refrigeration display case, commercial glass refrigerator and freezer door, and brazed plate heat exchanger for industrial heating and cooling, and residential climate control applications. The company was incorporated in 1947 and is headquartered in Downers Grove, Illinois.